Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4037/ccn2012613 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The risk of failure of subcutaneous implantable cardioverter defibrillator therapy: from PRAETORIAN score to clinical practice.
Europace
January 2025
Institute of Cardiology, IRCCS Azienda Ospedaliero Universitaria di Bologna, Italy.
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is an alternative to traditional ICDs. The PRAETORIAN score, based on chest radiographs, has been validated to predict the probability of successful S-ICD defibrillation testing by assessing factors like fat thickness between the coil and sternum and generator placement.
Objective: This study evaluated the correlation between the PRAETORIAN score and clinical characteristics, as well as implantation variables.
Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator.
ESC Heart Fail
October 2024
Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Article Synopsis
- - The study investigates the relationship between obesity and heart failure in patients using a wearable cardioverter-defibrillator, finding that those with a BMI over 30 kg/m^2 had better left ventricular ejection fraction improvements than patients with lower BMIs.
- - Despite similar adherence to using the defibrillator and rates of arrhythmic events across different BMI groups, patients with a BMI over 30 experienced significantly lower rehospitalization rates for cardiovascular issues compared to those with a BMI between 25-30.
- - At a two-year follow-up, mortality rates were notably lower for the highest BMI group (5.9%) compared to those with a BMI under 25 (7.5%), highlighting a potential 'ob
Circadian (diurnal/nocturnal) pattern of cardiac arrhythmias.
Heart Rhythm
October 2024
Euroclinic Hospital, Athens, Greece. Electronic address:
Article Synopsis
- * The review discusses how daily rhythms affect arrhythmia events and emphasizes the need for a comprehensive approach in diagnosing and treating these issues, especially considering factors like sleep disorders and comorbidities.
- * Effective treatments for nocturnal arrhythmias may involve adjusting medication timing, addressing underlying health conditions like obesity and sleep apnea, and utilizing specialized therapies, which can reduce severe heart issues and the need for invasive procedures.
Detection of Ventricular Tachycardia by an Implantable Cardiac Monitor 8 Months Post-myocardial Infarction.
J Innov Card Rhythm Manag
September 2024
Cardiology Department, Ospedale Santa Maria della Pietà, Nola, Italy.
Following a non-ST-elevation myocardial infarction (MI), a 68-year-old hypertensive, severely obese woman with 45% left ventricular ejection fraction underwent an implantable cardiac monitor (ICM) insertion. After 8 months, the ICM remotely transmitted multiple non-sustained ventricular tachycardia episodes. Symptomatic during these events, the patient underwent an invasive electrophysiologic stimulation, which induced ventricular arrhythmia.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!